Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Odontology ; 97(1): 51-3, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19184298

ABSTRACT

Although four-rooted mandibular first molars have been observed on a few occasions in the literature, to the best of our knowledge, four-rooted second molars have not been reported. Here, we describe a mandibular second molar with four roots and canals: two mesial and two distal. Mesial roots were separated in the cervical one-third near the cervical margin, while distal roots were divided at a lower level in the middle one-third of the root. We discuss the possibility of different root and canal variations of the mandibular second molar from a developmental point of view.


Subject(s)
Dental Pulp Cavity/abnormalities , Molar/abnormalities , Tooth Root/abnormalities , Dental Pulp Cavity/pathology , Female , Humans , Mandible , Molar/pathology , Odontometry , Tooth Crown/pathology , Tooth Root/pathology , Young Adult
2.
Odontology ; 95(1): 16-23, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17660977

ABSTRACT

The main purpose of this study was to investigate the root and canal morphology of Sri Lankan mandibular molars and to determine the affinities of these morphological variations to those of people of European and Asian origin. Two hundred mandibular first and second molars were examined. The number of roots and the prevalence of C-shaped (gutter-shaped) roots in mandibular second molars were recorded. Root canal morphology was studied using a clearing technique. The examination of root canal systems of the teeth was based on Vertucci's classification. Among mandibular first molars, only 3% had three roots. Mesial roots of the first molar typically presented with two canals and two apical foramina with type IV, V, or VI canal configuration. Most distal roots of the first molar presented with a type I canal configuration. The remainder were distributed mainly between types III and V. Among mandibular second molars, 6% had single C-shaped roots, while C-shaped canals were found in only 2%. The majority of mesial roots of the second molar showed one or two canals, with one apical foramen with type I, II, or III canal morphology. In addition, the distal root commonly showed type I canal configuration. Intercanal communications and lateral canals were more frequently seen in the first molar than in the second. The root canal morphology in mandibular molars varies among population groups. Mandibular root and canal morphology of Sri Lankan people has closer affinities with that of people of European than of East Asian origin.


Subject(s)
Dental Pulp Cavity/anatomy & histology , Molar/anatomy & histology , Tooth Root/anatomy & histology , Adult , Asian People , Dentition, Permanent , Female , Humans , Male , Mandible , Middle Aged , Sri Lanka , White People
3.
CNS Drug Rev ; 12(1): 9-20, 2006.
Article in English | MEDLINE | ID: mdl-16834755

ABSTRACT

Recanalization and neuroprotection have been mainly targeted for the specific treatment of acute ischemic stroke. Free radicals play a crucial role in brain ischemic injury by exacerbating membrane damage through peroxidation of unsaturated fatty acids of cell membrane, leading to neuronal death and brain edema. Free radicals have been implicated in stroke pathophysiology as pivotal contributors to cell injury. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one) is a novel potent free radical scavenger that has been clinically used to reduce the neuronal damage following ischemic stroke. Edaravone exerts neuroprotective effects by inhibiting endothelial injury and by ameliorating neuronal damage in brain ischemia. Edaravone provides the desirable features of NOS: it increases eNOS (beneficial NOS for rescuing ischemic stroke) and decreases nNOS and iNOS (detrimental NOS). Post- reperfusion brain edema and hemorrhagic events induced by thrombolytic therapy may be reduced by edaravone pretreatment. Increased productions of superoxide and NO in the brain after reperfusion and a concomitant surge in oxygen free radicals with increased NO during recirculation lead to formation of peroxynitrite, a superpotent radical. Edaravone, which inhibits oxidation and enhances NO production derived from increased eNOS expression, may improve and conserve cerebral blood flow without peroxynitrite generation during reperfusion. Clinical experience with edaravone suggests that this drug has a wide therapeutic time window. The combination therapy (a thrombolytic plus edaravone) is likely to target brain edema, reduce stroke death and improve the recovery from neurological deficits in stoke patients.


Subject(s)
Antipyrine/analogs & derivatives , Cerebrovascular Disorders/drug therapy , Free Radical Scavengers , Neuroprotective Agents/therapeutic use , Animals , Antipyrine/pharmacology , Antipyrine/therapeutic use , Cerebrovascular Disorders/classification , Edaravone , Humans , Models, Biological , Neuroprotective Agents/pharmacology , Nitric Oxide/metabolism
4.
J Microbiol Methods ; 66(3): 460-5, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16522335

ABSTRACT

An evaluation on the applicability of Mitis Salivarius agar (MS) medium, commonly used for the detection of oral streptococci in human and animals, to dog specimens and the development of a new selective medium for isolating streptococci from the canine oral cavity are described. Oral samples from dogs were cultured on MS medium under anaerobic conditions. The predominant facultative anaerobic bacteria on MS plates were gram-negative rods. Selectivity of streptococci on MS medium was 21.2%. A new selective medium, designated MS-CAN-AE, was developed for the isolation of streptococci from the canine oral cavity. The average growth recovery of laboratory and clinically isolated strains of streptococci on MS-CAN-AE medium was 84.1% of that on MS medium. Gram-positive rods and gram-negative rods and cocci rarely grew on the MS-CAN-AE. The selectivity of MS-CAN-AE was 95.0% for clinical samples. MS-CAN-AE medium will be helpful for investigations of streptococci in the canine oral cavity.


Subject(s)
Bacteriological Techniques/methods , Dog Diseases/microbiology , Mouth Diseases/veterinary , Streptococcal Infections/veterinary , Streptococcus/isolation & purification , Agar , Animals , Culture Media , Dog Diseases/diagnosis , Dogs , Female , Male , Mouth Diseases/diagnosis , Mouth Diseases/microbiology , Streptococcal Infections/diagnosis , Streptococcal Infections/microbiology
5.
Atherosclerosis ; 179(1): 97-102, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15721014

ABSTRACT

Edaravone, a newly synthesized synthetic radical scavenger, has been identified and adopted as an anti-stroke agent. However, its mechanism and the effect of edaravone on lipoprotein oxidation are not fully understood. Therefore, whether edaravone could suppress oxidation of low-density lipoprotein (LDL) and be involved in the expression of endothelial nitric oxide synthase (eNOS) in relation to anti-atherogenesis by improving and conserving vascular circulation was investigated. We investigated the in vitro effects of edaravone on copper- and endothelial cell-mediated LDL oxidation, and the expression of eNOS in human umbilical vein endothelial cells (HUVEC) modulated by oxidized LDL. The in vivo effect of edaravone on antioxidative effect was also studied in male rats intravenously administered with edaravone. Edaravone apparently inhibited copper- and HUVEC-mediated LDL oxidation at the concentration equivalent to serum concentrations in clinical use. The intravenous administration of edaravone also enhanced serum radical-scavenging property in rats. We tested the effect of edaravone on protein and mRNA expression of eNOS in HUVEC. Edaravone enhanced eNOS expression in HUVEC, presumably because of increased stability of eNOS mRNA, and reversed eNOS expression reduced by oxidized LDL nearly to the control levels. The present study demonstrates for the first time that edaravone increases eNOS expression with the inhibition of LDL oxidation, and that edaravone can reverse oxidized LDL-mediated reduction in eNOS expression in endothelial cells. The preventive action of edaravone from ischemic disease consequence may be attributed to these eNOS up-regulation with decreased oxidation.


Subject(s)
Antipyrine/analogs & derivatives , Antipyrine/pharmacology , Free Radical Scavengers/pharmacology , Lipoproteins, LDL/metabolism , Nitric Oxide Synthase/metabolism , Animals , Antioxidants/pharmacology , Antipyrine/blood , Blood Proteins/metabolism , Copper/metabolism , Edaravone , Free Radical Scavengers/blood , Injections, Intravenous , Male , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase Type III , Oxidation-Reduction , RNA Stability/drug effects , RNA, Messenger/metabolism , Rats , Rats, Wistar
6.
Biochim Biophys Acta ; 1673(3): 149-59, 2004 Aug 04.
Article in English | MEDLINE | ID: mdl-15279886

ABSTRACT

We have constructed a metabolic model describing the H2O2 elimination by mammalian cells. It comprises three compartments (medium, cytosol, and peroxisome) separated by cytoplasmic and peroxisomal membranes, and H2O2 moves across the membranes with different permeation rate constants. Catalase localizes to peroxisomes, while glutathione peroxidase (GPx) and GSH recycling system (glutathione reductase (GR) and the oxidative pentose phosphate pathway (PPP)) localize to cytosol. The rates of individual enzyme reactions were computed using the experimentally determined activities and rate equations known for mammalian enzymes. Using the model, the concentration dependence of H2O2 elimination rate was obtained by numerical simulation and was compared with experimental data obtained previously with cultured mammalian cells (fibroblasts, human umbilical vein endothelial cells (HUVEC), and PC12 cells). The model was shown to be able to reproduce the data well by assuming appropriate values for the permeability rate constants. The H2O2 permeability coefficients thus estimated for cytoplasmic and peroxisomal membranes were in the same order of magnitude, except that the value for cytoplasmic membrane of PC12 cell was significantly smaller. The results suggest that the membrane permeability is one of the rate-limiting factors in the H2O2 elimination by mammalian cells. Using the model and estimated parameter values, we have examined the rate-limiting enzyme of the metabolic system, as well as the intracellular H2O2 concentration under steady-state and non-steady-state conditions.


Subject(s)
Cytoplasm/metabolism , Hydrogen Peroxide/metabolism , Models, Biological , Peroxisomes/metabolism , Animals , Cells, Cultured , Cytoplasm/enzymology , Humans , NADP/metabolism , Permeability , Peroxisomes/enzymology
7.
Clin Chim Acta ; 345(1-2): 161-70, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15193991

ABSTRACT

BACKGROUND: Increased oxidative stress is considered to be causative for cardiovascular disease (CVD) in smokers, but its mechanisms are still unclear. We compared oxidative stress markers between male smokers and male nonsmokers. METHODS: Twenty-three healthy men (11 nonsmokers and 12 smokers) were enrolled, and blood samples after 12 h of fasting were collected to assess plasma lipids and oxidative stress markers. The effects of iron loading on 12-lipoxygenase (12-LO) expression and activity in human umbilical vein endothelial cells (HUVECs) were tested in vitro to investigate the relevance of iron to oxidation potential in vivo. RESULTS: Higher levels of plasma-oxidized low-density lipoprotein (LDL) and lipid peroxide (LPO), and higher oxidizability of LDL were observed in smokers than in nonsmokers. Higher levels of serum iron and lower levels of plasma vitamin E were observed in smokers than in nonsmokers. Stepwise multiple regression analysis showed that serum iron was an independent determinant for both plasma-oxidized LDL and lag time of LDL oxidation. Iron loading enhanced 12-LO expression threefold and its activity 1.5-fold. Moreover, iron loading decreased catalase expression by 50% and significantly reduced its activity by 75%. CONCLUSIONS: Enhanced oxidative stress in smokers may be due to increased iron levels. Iron-induced modulation of expression and activity of 12-LO and catalase may be relevant to increased iron-related oxidative stress as observed in smokers.


Subject(s)
Catalase/metabolism , Iron/blood , Lipoproteins, LDL/blood , Lipoxygenase/metabolism , Smoking/blood , Adult , Body Mass Index , Endothelial Cells/metabolism , Glutathione Peroxidase/metabolism , Humans , Hydrogen Peroxide/metabolism , Male , Oxidation-Reduction
8.
Mol Biol Cell ; 15(3): 1387-96, 2004 Mar.
Article in English | MEDLINE | ID: mdl-14699071

ABSTRACT

Mitogen-activated protein kinase (MAPK) (extracellular signal-regulated kinase) prevents DNA replication and parthenogenesis in maturing oocytes. After the meiotic cell cycle in starfish eggs, MAPK activity is maintained until fertilization. When eggs are fertilized, inactivation of MAPK occurs, allowing development to proceed. Without fertilization, highly synchronous apoptosis of starfish eggs starts 10 h after germinal vesicle breakdown, which varies according to season and individual animals. For induction of the apoptosis, MAPK should be activated for a definite period, called the MAPK-dependent period, during which eggs develop competence to die, although the exact duration of the period was unclear. In this study, we show that the duration of the MAPK-dependent period was approximately 8 h. Membrane blebbing occurred approximately 2 h after the MAPK-dependent period. Surprisingly, when MAPK was inhibited by U0126 after the MAPK-dependent period, activation of caspase-3 occurred earlier than in the control eggs. Thus, inactivation of MAPK is a prerequisite for apoptosis. Also, even in the absence of the inhibitor, MAPK was inactivated spontaneously when eggs began to bleb, indicating that inactivation of MAPK after the MAPK-dependent period acts upstream of caspase-3. Inactivation of MAPK also resulted in the activation of p38MAPK, which may contribute to apoptotic body formation.


Subject(s)
Apoptosis/physiology , Cell Surface Extensions/ultrastructure , Mitogen-Activated Protein Kinases/metabolism , Oocytes/metabolism , Starfish/metabolism , Animals , Butadienes/pharmacology , Enzyme Inhibitors/pharmacology , Female , MAP Kinase Signaling System/physiology , Meiosis/physiology , Microscopy, Electron , Nitriles/pharmacology , Oocytes/ultrastructure , Phosphorylation , p38 Mitogen-Activated Protein Kinases
SELECTION OF CITATIONS
SEARCH DETAIL
...